Rui Avelar Insider Trading Transactions
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Rui Avelar.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Rui Avelar. Rui Avelar is Chief Medical Officer in ANGIOTECH PHARMACEUTICALS INC ($ANPI) and See Remarks in Evolus, Inc. ($EOLS).
Latest Insider Trading Transactions of Rui Avelar
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb 01 2021 | EOLS | Evolus, Inc. | Avelar Rui | See Remarks | Grant | A | 0.00 | 90,000 | 0 | 224,103 | 134.1 K to 224.1 K (+67.11 %) |
| Jan 26 2021 | EOLS | Evolus, Inc. | Avelar Rui | See Remarks | Sell | S | 7.46 | 2,699 | 20,135 | 134,103 | 136.8 K to 134.1 K (-1.97 %) |
| May 15 2020 | EOLS | Evolus, Inc. | Avelar Rui | See Remarks | Grant | A | 0.00 | 40,000 | 0 | 136,802 | 96.8 K to 136.8 K (+41.32 %) |
| Jan 24 2020 | EOLS | Evolus, Inc. | Avelar Rui | See Remarks | Option Exercise | A | 10.19 | 45,000 | 458,550 | 45,000 | |
| Jan 24 2020 | EOLS | Evolus, Inc. | Avelar Rui | See Remarks | Grant | A | 0.00 | 26,000 | 0 | 96,802 | 70.8 K to 96.8 K (+36.72 %) |
| Jan 08 2020 | EOLS | Evolus, Inc. | Avelar Rui | See Remarks | Sell | S | 10.71 | 39,442 | 422,282 | 70,802 | 110.2 K to 70.8 K (-35.78 %) |
| Dec 11 2019 | EOLS | Evolus, Inc. | Avelar Rui | See Remarks | Option Exercise | M | 9.98 | 10,020 | 100,000 | 189,682 | |
| Dec 11 2019 | EOLS | Evolus, Inc. | Avelar Rui | See Remarks | Buy | M | 9.98 | 10,020 | 100,000 | 110,244 | 100.2 K to 110.2 K (+10.00 %) |
| Jan 25 2019 | EOLS | Evolus, Inc. | Avelar Rui | See Remarks | Option Exercise | A | 16.19 | 60,000 | 971,400 | 60,000 | |
| Mar 09 2010 | ANPI | ANGIOTECH PHARMACE ... | Avelar Rui | Chief Medical Offic ... | Option Exercise | A | 1.09 | 135,000 | 147,150 | 790,000 | |
| Jun 25 2009 | ANPI | ANGIOTECH PHARMACE ... | Avelar Rui | Chief Medical Offic ... | Option Exercise | J | 17.41 | 60,000 | 1,044,600 | 655,000 | |
| Jun 25 2009 | ANPI | ANGIOTECH PHARMACE ... | Avelar Rui | Chief Medical Offic ... | Option Exercise | J | 21.39 | 200,000 | 4,277,600 | 715,000 | |
| Mar 11 2009 | ANPI | ANGIOTECH PHARMACE ... | Avelar Rui | Chief Medical Offic ... | Option Exercise | A | 0.38 | 200,000 | 76,000 | 915,000 | |
| Dec 10 2008 | ANPI | ANGIOTECH PHARMACE ... | Avelar Rui | Chief Medical Offic ... | Option Exercise | A | 0.21 | 200,000 | 42,000 | 765,000 |
Page: 1